pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,831 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Marketed
avelumab
Bavencio (avelumab)
Merkel Cell Carcinoma
EMD Serono Inc
1 catalysts
Marketed
axitinib SR
AXPAXLI (axitinib)
Wet (Neovascular / Exudative) Macular Degeneration
Vascular endothelial growth factor receptor
$OCULOCULAR THERAPEUTIX, INC
1 catalysts
Marketed
belantamab mafodotin
Blenrep (belantamab mafodotin-blmf)
Refractory Multiple Myeloma
GlaxoSmithKline LLC
← prev
page 5 of 62
next →
131
Pain89
Neurology1
1 catalysts
Phase 3
berubicin hydrochloride
Recurrent Glioblastoma Multiforme (GBM)
DNA topoisomerase II
$CNSPCNS Pharmaceuticals, Inc.
1 catalysts
Phase 2
brentuximab vedotin
Adcetris (brentuximab vedotin)
Angioimmunoblastic T-Cell Lymphoma (AITL)/Immunoblastic Lymphadenopathy
TubulinTumor necrosis factor receptor superfamily member 8
$PFEPFIZER INC
1 catalysts
Marketed
busulfan
Myleran (busulfan)
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)
Woodward Pharma Services LLC
1 catalysts
Phase 2
cadonilimab
Hepatocellular Carcinoma
Programmed cell death protein 1Cytotoxic T-lymphocyte protein 4
Akeso Inc
1 catalysts
pre_registration
camizestrant
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
Estrogen receptor
$AZNASTRAZENECA PLC
1 catalysts
Marketed
ceritinib
Zykadia (ceritinib)
Non-Small Cell Lung Cancer
$NVSNOVARTIS AG
1 catalysts
Phase 3
cisplatin
Hyalcis (cisplatin)
Lip Cancer
Privo Technologies Inc
1 catalysts
Phase 3
daraxonrasib
Non-Small Cell Lung Cancer
$RVMDRevolution Medicines, Inc.
1 catalysts
Marketed
denosumab
Prolia (denosumab)
Glucocorticoid-Induced Osteoporosis
$AMGNAMGEN INC
1 catalysts
Phase 2
dostarlimab
Jemperli (dostarlimab-gxly)
Rectal Cancer
Programmed cell death protein 1
$GSKGSK plc
1 catalysts
Marketed
eflornithine hydrochloride
Iwilfin (eflornithine hydrochloride)
Neuroblastoma
US WorldMeds LLC
1 catalysts
Phase 2
emavusertib hydrochloride
Chronic Lymphocytic Leukemia (CLL)
$CRISCURIS INC
1 catalysts
Marketed
etoposide
Etopophos (etoposide)
Small-Cell Lung Cancer
H2-Pharma LLC
1 catalysts
Marketed
fruquintinib
Fruzaqla (fruquintinib)
Metastatic Colorectal Cancer
Takeda Pharmaceuticals USA Inc
1 catalysts
pre_registration
fuzuloparib
fuzuloparib [INN]
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Jiangsu Hengrui Pharmaceuticals Co Ltd
1 catalysts
pre_registration
iberdomide hydrochloride
Refractory Multiple Myeloma
Bristol-Myers Squibb Co
1 catalysts
Marketed
imlunestrant tosylate
Inluriyo (imlunestrant tosylate)
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
Eli Lilly and Co
1 catalysts
Phase 2
navlimetostat
Non-Small Cell Lung Cancer
Bristol-Myers Squibb Co
1 catalysts
Marketed
olaparib
Lynparza (olaparib)
Epithelial Ovarian Cancer
AstraZeneca Pharmaceuticals LP
1 catalysts
Marketed
paltusotine hydrochloride
Palsonify (paltusotine hydrochloride)
Carcinoid Syndrome (Malignant Carcinoid Syndrome)
$CRNXCrinetics Pharmaceuticals, Inc.
1 catalysts
Marketed
pertuzumab biosimilar
Poherdy (pertuzumab-dpzb)
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast…
EirGenix Inc
1 catalysts
Phase 3
raludotatug deruxtecan
Adenocarcinoma Of The Gastroesophageal Junction
Daiichi Sankyo Co Ltd
1 catalysts
pre_registration
sacituzumab govitecan
Trodelvy (sacituzumab govitecan)
Triple-Negative Breast Cancer (TNBC)
Tumor-associated calcium signal transducer 2DNA topoisomerase 1
$GILDGILEAD SCIENCES, INC.
1 catalysts
Phase 2
samuraciclib
samuraciclib [INN]
Breast Cancer
Carrick Therapeutics Ltd
1 catalysts
Phase 3
serplulimab
Small-Cell Lung Cancer
Programmed cell death protein 1
Shanghai Henlius Biotech Inc
1 catalysts
Marketed
sevabertinib
Hyrnuo (sevabertinib)
Non-Small Cell Lung Cancer
Bayer AG
1 catalysts
Phase 2
soficabtagene geleucel
soficabtagene geleucel [INN]
T-Cell Acute Lymphocytic Leukemia (T-Cell Acute Lymphoblastic Leukaemia)
Wugen Inc
1 catalysts